GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (OTCPK:AVHHL) » Definitions » Cyclically Adjusted Price-to-FCF

AVITA Medical (AVITA Medical) Cyclically Adjusted Price-to-FCF : (As of May. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is AVITA Medical Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


AVITA Medical Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for AVITA Medical's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical Cyclically Adjusted Price-to-FCF Chart

AVITA Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AVITA Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of AVITA Medical's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, AVITA Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Cyclically Adjusted Price-to-FCF falls into.



AVITA Medical Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

AVITA Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, AVITA Medical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.172/131.7762*131.7762
=-0.172

Current CPI (Mar. 2024) = 131.7762.

AVITA Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.064 100.560 -0.084
201409 -0.012 100.428 -0.016
201412 -0.027 99.070 -0.036
201503 -0.016 99.621 -0.021
201506 -0.087 100.684 -0.114
201509 -0.013 100.392 -0.017
201512 -0.057 99.792 -0.075
201603 -0.015 100.470 -0.020
201606 -0.077 101.688 -0.100
201609 -0.013 101.861 -0.017
201612 -0.049 101.863 -0.063
201703 -0.008 102.862 -0.010
201706 -0.058 103.349 -0.074
201709 -0.014 104.136 -0.018
201712 -0.094 104.011 -0.119
201803 -0.010 105.290 -0.013
201806 -0.079 106.317 -0.098
201809 -0.009 106.507 -0.011
201812 -0.011 105.998 -0.014
201903 -0.011 107.251 -0.014
201906 -0.094 108.070 -0.115
201909 -0.054 108.329 -0.066
201912 -0.048 108.420 -0.058
202003 -0.071 108.902 -0.086
202006 -0.057 108.767 -0.069
202009 -0.074 109.815 -0.089
202012 -0.056 109.897 -0.067
202103 -0.078 111.754 -0.092
202106 -0.033 114.631 -0.038
202109 -0.005 115.734 -0.006
202112 -0.040 117.630 -0.045
202203 -0.076 121.301 -0.083
202206 -0.030 125.017 -0.032
202209 -0.023 125.227 -0.024
202212 -0.028 125.222 -0.029
202303 -0.074 127.348 -0.077
202306 -0.075 128.729 -0.077
202309 -0.075 129.860 -0.076
202312 -0.088 129.419 -0.090
202403 -0.172 131.776 -0.172

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AVITA Medical  (OTCPK:AVHHL) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


AVITA Medical Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of AVITA Medical's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


AVITA Medical (AVITA Medical) Business Description

Traded in Other Exchanges
Address
28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.